| Product No | EMEA/H/C/004821 |
|---|---|
| Brand Name | Isturisa |
| Nonproprietary Name | osilodrostat |
| API | Osilodrostat phosphate |
| ATC Code | H02CA02 |
| Indications | Isturisa is indicated for the treatment of endogenous Cushing’s syndrome in adults. |
| Orphan Drug | yes |
| Generics | no |
| Marketing Authorization Holder | Recordati Rare Diseases |
| Status | Authorised(授权) |
| Authorization Date | 2020-01-09 |
| Version | 4 |
| Condition Approval | no |
| Exceptions | no |
| Biosimilar | no |
| Details | 查看 (公众评估报告、授权细节、产品规格/剂型、标签、历史评估信息) |
Extended Information